We are live on
!
Find out more
OAM
Oxford Asset Management Portfolio holdings
AUM
$232M
1-Year Est. Return
31%
This Fund
S&P 500
This Quarter
Est. Return
+14.01%
1 Year Est. Return
+31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.6B
AUM Growth
-$554M
(-13%)
Cap. Flow
-$798M
Cap. Flow
% of AUM
-22.13%
Top 10 Holdings %
Top 10 Hldgs %
9.27%
Holding
2,296
New
622
Increased
390
Reduced
675
Closed
586
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$41.8M |
| 2 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$32.6M |
| 3 |
KEM
KEMET Corporation
KEM
|
+$27.5M |
| 4 |
CBPX
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
|
+$26.5M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$48.1M |
| 2 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$42.4M |
| 3 |
VSM
Versum Materials, Inc.
VSM
|
+$38.4M |
| 4 |
STNL
Sentinel Energy Services Inc. Class A Common Stock
STNL
|
+$26.3M |
| 5 |
CBM
Cambrex Corporation
CBM
|
+$24.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.71% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 13.6% |
| 4 | Industrials | 12.95% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRKL
976
DELISTED
Brookline Bancorp
BRKL
| $824K | 0.02% |
+50,088
| New | +$789K |
|
977
Health Catalyst
HCAT
$128M
| $824K | 0.02% |
+23,751
| New | +$786K |
|
978
Charles River Laboratories
CRL
$12.8B
| $821K | 0.02% |
5,377
+1,332
| +33% | +$184K |
|
979
Haverty Furniture Companies
HVT
$454M
| $817K | 0.02% |
40,507
-50,369
| -55% | -$1.02M |
|
980
Enanta Pharmaceuticals
ENTA
$400M
| $816K | 0.02% |
13,203
-6,329
| -32% | -$392K |
|
981
Verizon
VZ
$196B
| $814K | 0.02% |
13,260
-315,620
| -96% | -$19M |
|
982
Williams-Sonoma
WSM
$29.6B
| $814K | 0.02% |
22,164
-17,176
| -44% | -$597K |
|
983
Editas Medicine
EDIT
$442M
| $812K | 0.02% |
27,425
+14,498
| +112% | +$362K |
|
984
Avnet
AVT
$7.92B
| $811K | 0.02% |
19,115
+9,556
| +100% | +$394K |
|
985
Foster
FSTR
$432M
| $810K | 0.02% |
41,790
-10,862
| -21% | -$211K |
|
986
Tenaris
TS
$26.8B
| $810K | 0.02% |
+35,768
| New | +$769K |
|
987
Powell Industries
POWL
$7.71B
| $809K | 0.02% |
49,560
-25,761
| -34% | -$361K |
|
|
ALTA
988
DELISTED
Altabancorp
ALTA
| $807K | 0.02% |
26,805
-6,664
| -20% | -$195K |
|
989
Jones Lang LaSalle
JLL
$16.7B
| $802K | 0.02% |
4,607
-6,287
| -58% | -$989K |
|
990
Pacira BioSciences
PCRX
$997M
| $801K | 0.02% |
17,684
-19,993
| -53% | -$849K |
|
|
PLYM
991
DELISTED
Plymouth Industrial REIT
PLYM
| $801K | 0.02% |
43,578
-18,690
| -30% | -$344K |
|
992
Advance Auto Parts
AAP
$3.49B
| $800K | 0.02% |
+4,992
| New | +$800K |
|
993
Central Garden & Pet Co
CENT
$2.8B
| $799K | 0.02% |
+32,133
| New | +$764K |
|
994
Intellia Therapeutics
NTLA
$1.67B
| $798K | 0.02% |
54,375
+18,402
| +51% | +$256K |
|
995
RBB Bancorp
RBB
$455M
| $798K | 0.02% |
37,686
+22,235
| +144% | +$452K |
|
996
Harvard Bioscience
HBIO
$29.2M
| $797K | 0.02% |
26,133
-4,802
| -16% | -$138K |
|
997
NWPX Infrastructure Inc
NWPX
$1.15B
| $793K | 0.02% |
+23,811
| New | +$751K |
|
998
NewMarket
NEU
$8.18B
| $792K | 0.02% |
1,628
-2,197
| -57% | -$1.06M |
|
999
Oppenheimer Holdings
OPY
$1.2B
| $791K | 0.02% |
28,796
+6,301
| +28% | +$176K |
|
|
BCPC
1000
Balchem Corp
BCPC
$5.72B
| $791K | 0.02% |
7,784
+2,457
| +46% | +$248K |
|
Similar funds
KG
VOMP
TLA
RWS
SC
RWMG
TW
NTIC
Oxford Asset Management's Q4 2019 Portfolio in Review
As of Q4 2019, Oxford Asset Management held 2,296 positions worth $3.6B, down 13% from $4.16B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Oxford Asset Management withdrew a net $798M in Q4 2019, closing 586 positions and reducing 675 holdings. Its most notable exit was Medidata Solutions, Inc., an estimated $48.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Oxford Asset Management opened a new position in WABCO HOLDINGS INC. worth $42M.
- Oxford Asset Management's largest Q4 2019 buy was WABCO HOLDINGS INC.: 310,063 shares worth $42M.
- Oxford Asset Management added most to China Biologic Products Holdings, Inc. in Q4 2019, an estimated $16.2M increase.
- Oxford Asset Management's biggest Q4 2019 reduction was Intuit, cutting an estimated $22.5M.
- Oxford Asset Management fully exited Medidata Solutions, Inc. in Q4 2019, selling an estimated $48.1M.
- Oxford Asset Management's ten largest holdings make up 9.3% of its $3.6B portfolio in Q4 2019.
- Oxford Asset Management opened 622 new positions and closed 586 in Q4 2019.
- Oxford Asset Management's portfolio value fell 13% quarter-over-quarter to $3.6B.
Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.